| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), CYDY's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.87M | - | - | |
| Other | 3.25M | - | - | |
| CEO | 2.50M | - | - | |
| Dir | 574.4K | - | - | |
| Dir | 574.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2015 | Alpha Advisors, LLC | 10% Owner, Indirect | Buy | 140,843 | $0.50 | $70,421.50 | +6.7% | |
| Jun 5, 2015 | Dockery Carl | Director, 10% Owner | Buy | 140,843 | $0.50 | $70,421.50 | +6.7% |